He appointed the first of two committees, the first consisting of nearly 20 representatives from government, labor and health – including Ken Raske, leader of the powerful healthcare lobby Greater New York Hospital Association; Northwell Health chief Michael Dowling, who has served alongside the governor in numerous coronavirus briefings throughout the height of the pandemic; 1199 George Gresham of SEIU; as well as Cuomo loyalists, SUNY’s new chancellor Jim Malatras and state budget director Robert Mujica.
This review board will advise the governor on the proper implementation, distribution, data collection, and security protocols, “so I can look at the camera and tell New Yorkers it’s safe.” . I want to make sure we know it’s safe to take, ”Cuomo explained.
“On the vaccine issue, like everything else in this country, it’s partisan and it’s called into question and there is controversy about it. The way the federal government handled the vaccine, there are now serious questions about whether or not the vaccine has become politicized, ”Cuomo told reporters at a news briefing in Manhattan.
“The president is in conflict with the FDA again. The FDA says it wants to make the approval more rigorous, more transparent. The president says they are trying to politicize him. Why would the FDA politicize approval? Between the president and the FDA, a single entity has engaged in the political process and is heading towards election day, ”he said.
“It’s not the FDA. I don’t think Dr Hahn is running for anything. Is Dr Hahn running for office? No. So, I don’t see what political interest Dr. Hahn, chief of the FDA has. President Trump is engaged in the political process and has election day. ”
“The vaccination plan will include prioritization of the vaccine. Who receives the vaccine first based on medical standards, nothing else. How to distribute it, who can administer it, how to train these people, how to train them now? ”
The governor will appoint a second group of doctors, scientists and health experts in the near future, officials say they will assess the medical safety and effectiveness of the drug.
Trump said last week that the national billion dollar coronavirus vaccine effort was in its “final phase” and that the country’s top doctors and scientists had been working around the clock since last January to find an effective product.
Pharmaceutical companies like Pfizer are said to be near end and could produce results as early as the end of October.
The United States recorded 200,000 deaths from the virus on Tuesday.
New York has tracked 33,090 confirmed and suspected coronavirus deaths according to data reported Thursday by Johns Hopkins University, and the State Department of Health has recorded 25,439 confirmed virus deaths.